Actein enhances TRAIL effects on suppressing gastric cancer progression by activating p53/Caspase-3 signaling

Zhi-Chao Yang1, Ji Ma1

  • 1Huaihe Hospital of Henan University, Southern Institute of Huaihe Hospital of Henan University, No. 8 Hubei Road, 475000 Henan, China.

Insights

Actein (ACT) enhances TRAIL therapy for gastric cancer. Combining ACT with TRAIL synergistically induces apoptosis and inhibits tumor growth without toxicity, offering a new therapeutic strategy.

Area of Science:

  • Pharmacology
  • Oncology
  • Molecular Biology

Background:

  • Actein (ACT), a triterpene glycoside from Cimicifuga foetida, shows promise in breast cancer.
  • The therapeutic potential of ACT in gastric cancer remains largely unexplored.

Purpose of the Study:

  • To investigate the in vitro and in vivo effects of ACT on gastric cancer.
  • To explore the synergistic interaction between ACT and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in gastric cancer cells.

Main Methods:

  • In vitro assays to assess apoptosis induction and protein expression.
  • In vivo mouse xenograft model to evaluate tumor growth inhibition.
  • Analysis of apoptosis-related proteins, including Caspases, Bcl-2 family members, and decoy receptors.

Main Results:

  • Gastric cancer cells were insensitive to TRAIL monotherapy but sensitive when combined with ACT.
  • ACT sensitized cells to TRAIL by upregulating decoy receptors (DcR1 and DcR2) dependent on p53, enhancing Caspase cleavage.
  • Combined ACT and TRAIL treatment decreased anti-apoptotic proteins (Bcl-2, Mcl-1) and increased pro-apoptotic proteins (Bad, Bak).
  • In vivo, combination therapy significantly inhibited gastric cancer growth without observed toxicity.

Conclusions:

  • ACT acts synergistically with TRAIL to induce apoptosis and inhibit gastric cancer growth.
  • This combination therapy represents a promising strategy for gastric cancer treatment by enhancing TRAIL-induced anti-cancer effects.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.0K
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.6K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.7K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
13.5K
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside...
14.4K